Arkolith/Insider Trading/OPNT/Form 4

Sinclair Michael

Director, 10% OwnerOPIANT PHARMACEUTICALS, INC. (OPNT) · full profile →Form 4 · filed Mar 3, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
3 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 2, 2023Disposed to issuer(D)40K$20.00$800K0
Mar 2, 2023Disposed to issuer(D)27K$20.00$549K0
Mar 2, 2023Disposed to issuer(D)23K$20.00$454K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 2, 2023Disposed to issuer(D)75K—$00
Mar 2, 2023Disposed to issuer(D)100K—$00
Mar 2, 2023Disposed to issuer(D)250K—$00

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001385508-23-000063) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML